Press Releases & Statements

June 05, 2020

IPM Statement: In Solidarity and Against Injustice

June 5, 2020—Over the past few months, we have found our lives disrupted by the novel coronavirus. Now we are confronting a much older and more insidious horror as we grapple with the deaths of... More »

June 13, 2019

Final Results of Open-label Study of IPM’s Dapivirine Vaginal Ring Show Increased Use and Suggest Lower Infection Rates Compared to Earlier Phase III Study

Durban (13 June 2019)—Final data from an open-label extension study of the monthly dapivirine ring show increased product use compared to a previous Phase III study. In addition, modeling data... More »

March 06, 2018

Interim Results of Open-Label Study of IPM’s Dapivirine Vaginal Ring Find Increased Product Use and Suggest Greater HIV Risk Reduction

Compared to earlier Phase III study, women’s adherence to monthly HIV prevention ring is higher and data suggest infection rates are lowerBOSTON (March 6, 2018) — Interim data from a large open-label... More »

December 13, 2017

IPM’s Three-month HIV Prevention Vaginal Ring Begins First Clinical Trial

Next-generation product builds on IPM’s promising one-month microbicide ringSILVER SPRING, Md. (December 13, 2017) – The nonprofit International Partnership for Microbicides (IPM) announced today the... More »

December 08, 2017

IPM Receives Multi-year Award From Danish Government to Advance Woman-Centered HIV Prevention and Sexual and Reproductive Health Technologies

Funding will support development, potential introduction of IPM’s monthly dapivirine ring, and other new long-acting products that could empower women with more options to protect their own... More »